137 related articles for article (PubMed ID: 36806581)
1. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
Shu Y; Lu Y; Pang X; Zheng W; Huang Y; Li J; Ji J; Zhang C; Shen P
Oncotarget; 2016 Nov; 7(47):76984-76994. PubMed ID: 27769068
[TBL] [Abstract][Full Text] [Related]
3. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
Ros S; Flöter J; Kaymak I; Da Costa C; Houddane A; Dubuis S; Griffiths B; Mitter R; Walz S; Blake S; Behrens A; Brindle KM; Zamboni N; Rider MH; Schulze A
Oncogene; 2017 Jun; 36(23):3287-3299. PubMed ID: 28092678
[TBL] [Abstract][Full Text] [Related]
4. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
[TBL] [Abstract][Full Text] [Related]
6. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1 upregulates 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-4 expression in A549 and MCF-10A cells.
Altunok TH; Muchut RJ; Iglesias AA; Yalcin A
Cell Biochem Funct; 2023 Dec; 41(8):1220-1229. PubMed ID: 37707291
[TBL] [Abstract][Full Text] [Related]
8. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.
Minchenko OH; Opentanova IL; Ogura T; Minchenko DO; Komisarenko SV; Caro J; Esumi H
Acta Biochim Pol; 2005; 52(4):881-8. PubMed ID: 16025159
[TBL] [Abstract][Full Text] [Related]
9. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression.
Shen C; Ding L; Mo H; Liu R; Xu Q; Tu K
J Cancer; 2021; 12(13):4099-4108. PubMed ID: 34093813
[TBL] [Abstract][Full Text] [Related]
11. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
Li X; Wu L; Zopp M; Kopelov S; Du W
Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
[TBL] [Abstract][Full Text] [Related]
12. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
13. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma.
Chan LK; Ho DW; Kam CS; Chiu EY; Lo IL; Yau DT; Cheung ET; Tang CN; Tang VW; Lee TK; Wong CC; Chok KS; Chan AC; Cheung TT; Wong CM; Ng IO
J Hepatol; 2021 Feb; 74(2):360-371. PubMed ID: 32918955
[TBL] [Abstract][Full Text] [Related]
14. Expression of Alternative Splice Variants of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-4 in Normoxic and Hypoxic Melanoma Cells.
Trojan SE; Dudzik P; Totoń-Żurańska J; Laidler P; Kocemba-Pilarczyk KA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445551
[TBL] [Abstract][Full Text] [Related]
15. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
[TBL] [Abstract][Full Text] [Related]
16. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
17. Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism.
Li B; Takeda K; Ishikawa K; Yoshizawa M; Sato M; Shibahara S; Furuyama K
Tohoku J Exp Med; 2012 Sep; 228(1):27-41. PubMed ID: 22892400
[TBL] [Abstract][Full Text] [Related]
18. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening.
Strohecker AM; Joshi S; Possemato R; Abraham RT; Sabatini DM; White E
Oncogene; 2015 Nov; 34(45):5662-76. PubMed ID: 25772235
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
[TBL] [Abstract][Full Text] [Related]
20. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]